TET2 and metastatic malignant neoplasm in the lymph nodes: The results showed that TET2/5hmC association was significantly associated with differentiation (χ2 = 82.249, P < 0.001), myometrial invasion (χ2 = 44.060, P < 0.001), lymph node metastasis (χ2 = 15.231, P = 0.002), and FIGO stage (χ2 = 38.769, P < 0.001).